tiprankstipranks
Axsome Therapeutics Inc (DE:19X)
FRANKFURT:19X
Holding DE:19X?
Track your performance easily

Axsome Therapeutics (19X) Financial Statements

3 Followers

Axsome Therapeutics Financial Overview

Axsome Therapeutics's market cap is currently ―. The company's EPS TTM is €-6.536; its P/E ratio is -13.43; Axsome Therapeutics is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is €-0.92. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 104.76M$ 87.17M$ 75.00M$ 71.53M$ 57.79M
Gross Profit$ 96.33M$ 79.11M$ 68.70M$ 64.15M$ 51.26M
EBIT$ -59.71M$ -74.48M$ -69.73M$ -98.27M$ -62.12M
EBITDA$ -56.98M$ -71.85M$ -67.27M$ -96.53M$ -60.38M
Net Income Common Stockholders$ -64.60M$ -77.19M$ -68.36M$ -98.65M$ -62.20M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 327.34M$ 315.66M$ 331.44M$ 386.19M$ 416.56M
Total Assets$ 561.46M$ 548.23M$ 545.73M$ 588.24M$ 600.86M
Total Debt$ 191.02M$ 190.60M$ 188.80M$ 186.37M$ 185.57M
Net Debt$ -136.32M$ -125.05M$ -142.64M$ -199.82M$ -230.99M
Total Liabilities$ 468.56M$ 445.37M$ 401.69M$ 397.26M$ 331.35M
Stockholders Equity$ 92.90M$ 102.83M$ 144.04M$ 190.98M$ 269.51M
Cash Flow-
Free Cash Flow$ -18.72M$ -30.16M$ -53.56M$ -30.37M$ -53.92M
Operating Cash Flow$ -18.63M$ -30.11M$ -53.47M$ -30.36M$ -53.55M
Investing Cash Flow$ -90.00K$ -52.00K$ -98.00K$ -7.00K$ -371.00K
Financing Cash Flow$ 30.41M$ 14.38M$ -1.19M$ -2.00K$ 33.37M
Currency in USD

Axsome Therapeutics Earnings and Revenue History

Axsome Therapeutics Debt to Assets

Axsome Therapeutics Cash Flow

Axsome Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis